2021年HIV-TRePS更新:在基线信息不完整时高度灵活且准确预测治疗反应
该研究利用全球大型数据集训练随机森林模型,预测病毒学失败后新方案的病毒学应答概率或病毒载量绝对变化。标准分类模型交叉验证和独立测试AUC为0.89,缺失变量模型AUC为0.78-0.90;标准绝对模型预测误差分别为0.65和0.69 log10 copies HIV RNA/mL,缺失变量模型为0.65-0.75 log10 copies HIV RNA/mL。所有模型均显著优于基因型加规则解释。
要点
- 标准分类模型预测病毒学应答的AUC为0.89,缺失变量模型AUC为0.78-0.90。
- 标准绝对模型预测病毒载量变化的平均绝对误差为0.65-0.69 log10 copies HIV RNA/mL。
- 所有模型均能识别对临床失败方案有效的替代方案,且优于基因型规则解释。
核心结论
- 最新模型即使在多个基线变量缺失时也能准确预测治疗反应,在资源有限环境中潜力显著提升。
主要发现
- 标准分类模型交叉验证和独立测试AUC为0.89,缺失变量模型AUC为0.78-0.90。
- 标准绝对模型交叉验证平均绝对误差0.65 log10 copies HIV RNA/mL,独立测试0.69 log10 copies HIV RNA/mL;缺失变量模型为0.65-0.75 log10 copies HIV RNA/mL。
- 所有模型均识别出对临床失败方案有效的替代方案,且显著优于基因型加规则解释。
临床怎么用
- 在资源有限且基线数据不完整时,可用HIV-TRePS模型辅助优化抗逆转录病毒治疗方案。
局限性
- 实现潜力的唯一障碍是医护人员使用该系统的意愿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: With the goal of facilitating the use of HIV-TRePS to optimize therapy in settings with limited healthcare resources, we aimed to develop computational models to predict treatment responses accurately in the absence of commonly used baseline data. METHODS: Twelve sets of random forest models were trained using very large, global datasets to predict either the probability of virological response (classifier models) or the absolute change in viral load in response to a new regimen (absolute models) following virological failure. Two 'standard' models were developed with all baseline variables present and 10 others developed without HIV genotype, time on therapy, CD4 count or any combination of the above. RESULTS: The standard classifier models achieved an AUC of 0.89 in cross-validation and independent testing. Models with missing variables achieved AUC values of 0.78-0.90. The standard absolute models made predictions that correlated significantly with observed changes in viral load with a mean absolute error of 0.65 log10 copies HIV RNA/mL in cross-validation and 0.69 log10 copies HIV RNA/mL in independent testing. Models with missing variables achieved values of 0.65-0.75 log10 copies HIV RNA/mL. All models identified alternative regimens that were predicted to be effective for the vast majority of cases where the new regimen prescribed in the clinic failed. All models were significantly better predictors of treatment response than genotyping with rules-based interpretation. CONCLUSIONS: These latest models that predict treatment responses accurately, even when a number of baseline variables are not available, are a major advance with greatly enhanced potential benefit, particularly in resource-limited settings. The only obstacle to realizing this potential is the willingness of healthcare professions to use the system.
引用
- Revell AD, Wang D, Perez-Elias MJ, et al. 2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings. J Antimicrob Chemother. 2021. PMID: 33792714. doi:10.1093/jac/dkab078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。